CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions

Clin Transplant. 2024 May;38(5):e15324. doi: 10.1111/ctr.15324.

Authors

Ilaria Gandolfini^{1

2}, Benedetta Mordà^{1

2}, Elene Martinelli^{1

2}, Marco Delsante^{1

2}, GiovanniMaria Rossi^{1

2}, Micaela Gentile^{1

2}, Sara Alibrandi^{1

2}, Daniel Salvetti^{1

2}, Enrico Fiaccadori^{1

2}, Alessandra Palmisano^{1

2}, Paolo Cravedi³, Umberto Maggiore^{1

2}

Affiliations

¹ Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Nephrology Unit, University Hospital of Parma, Parma, Italy.
³ Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PMID: 38678588
DOI: 10.1111/ctr.15324

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers* / analysis
Biomarkers* / blood
Chemokine CXCL10* / blood
Chemokine CXCL10* / metabolism
Chemokine CXCL9* / blood
Female
Graft Rejection / blood
Graft Rejection / diagnosis
Graft Rejection / etiology
Graft Rejection / immunology
Graft Survival
Humans
Inflammation / metabolism
Kidney Transplantation*
Male
Middle Aged
Prognosis

Substances

Chemokine CXCL10
Biomarkers
CXCL10 protein, human
Chemokine CXCL9
CXCL9 protein, human